RBC Capital Reiterates Outperform on QuidelOrtho, Maintains $61 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has reiterated an Outperform rating on QuidelOrtho (NASDAQ:QDEL) and maintained a price target of $61.
August 01, 2024 | 3:54 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital analyst Conor McNamara has reiterated an Outperform rating on QuidelOrtho and maintained a price target of $61.
The reiteration of an Outperform rating and the maintenance of a $61 price target by RBC Capital is a positive signal for investors, likely boosting short-term confidence and potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100